Low levels of HER2 extracellular domain (ECD) compared to intracelluar domain (ICD) in NeoALTTO may segregate benefit from lapatinib and trastuzumab in breast cancer Meeting Abstract
| Authors: | Rimm, D. L.; Carvajal-Hausdorf, D.; Harbeck, N.; Fumagalli, D.; Rodrik-Outmezguine, V.; delaPena, L.; deAzambuja, E.; Huober, J.; Baselga, J.; Piccart, M.; Holmes, E.; Pusztai, L. |
| Abstract Title: | Low levels of HER2 extracellular domain (ECD) compared to intracelluar domain (ICD) in NeoALTTO may segregate benefit from lapatinib and trastuzumab in breast cancer |
| Meeting Title: | 40th Annual San Antonio Breast Cancer Symposium (SABCS 2017) |
| Journal Title: | Cancer Research |
| Volume: | 78 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2017 Dec 5-9 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2018-02-01 |
| Language: | English |
| ACCESSION: | WOS:000425489400254 |
| PROVIDER: | wos |
| DOI: | 10.1158/1538-7445.SABCS17-P2-09-07 |
| Notes: | Meeting Abstract: P2-09-07 -- Source: Wos |
